M. S. Pranav

Definitive Hypofractionated Simultaneous Integrated Boost Intensity-modulated Radiotherapy (60 Gy in 25 Fractions) in Elderly Patients with Locally Advanced Head and Neck Cancer Ineligible for Concurrent Chemotherapy: A Prospective, Single-arm Feasibility Study

A BSTRACT Elderly patients with head and neck squamous cell carcinoma (HNSCC) often cannot tolerate prolonged conventional radiotherapy and are under-represented in trials. As the meta-analysis of chemotherapy in head and neck cancer meta-analysis shows the benefit of concurrent chemotherapy diminishes with a...